Advertisement

SUNNYVALE, Calif., Aug. 16, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that the Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital of Harvard Medical School and a leader in pioneering innovative technology to advance patient care, has treated its 2,000th patient with the CyberKnife® Robotic Radiosurgery System. The first center in New England to offer the CyberKnife System, the BIDMC achieved this significant milestone in less than six years.

The Keith C. Field CyberKnife Center at the BIDMC in recent history has used the CyberKnife System to treat an average of 450 patients per year with a wide range of intracranial and extracranial tumors as well as other functional conditions. The CyberKnife System complements and enhances the BIDMC's comprehensive array of diagnostic, therapeutic and surgical services for treating tumors and gives patients throughout New England access to an innovative, non-invasive treatment option. In November 2010, the BIDMC upgraded its CyberKnife facility to include the most advanced CyberKnife technology including the Iris™ Variable Aperture Collimator. This upgrade enables the hospital to deliver treatments more rapidly and efficiently, increasing overall patient throughput.

"The CyberKnife System continues to be a critical tool for us in the minimally-invasive treatment of tumors," said Irving Kaplan, MD, co-director of the Beth Israel Deaconess Medical Center Prostate Care Center and assistant professor of Radiation Oncology at Harvard Medical School. "The technology's unparalleled accuracy allows us to maximize healthy tissue sparing while delivering ablative doses of radiation and provide an overall more positive patient experience. At the BIDMC we a

'/>"/>

SOURCE

Advertisement
Advertisement